Thomas P Soloway
CIK 1454280 · Executive Vice President, CFO · last filed 2025-08-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
28
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Third Harmonic Bio, Inc. (THRD) Delisted | Director | — | $5.38 | — | $0 | 4 | 2024-06-10 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | — | $1.10 | — | $0 | 4 | 2023-06-08 |
| BOLD | Executive Vice President, CFO | 0 | $1.41 | $0 | $0 | 9 | 2020-01-15 |
Recent Filings · Page 3 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-02-02 | — | Grant (A) | — | $0 | |
| 2011-12-05 | — | Mixed | — | -$427.9K | |
| 2011-11-28 | — | Mixed | — | -$70.5K | |
| 2011-08-25 | — | Grant (A) | — | $0 | |
| 2011-02-03 | — | Grant (A) | — | $0 | |
| 2010-01-19 | — | Grant (A) | — | $0 | |
| 2009-02-17 | — | Grant (A) | — | $0 | |
| 2009-02-03 | — | Grant (A) | +31,234 | $0 |
Showing 21–28 of 28
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.